A Multicenter Phase Ib Trial of the Histone Deacetylase Inhibitor Entinostat in Combination with Pembrolizumab in Patients with Myelodysplastic Syndromes/neoplasms or Acute Myeloid Leukemia Refractory to Hypomethylating Agents.
ANNALS OF HEMATOLOGY（2024）
关键词
AML,MDS,Pembrolizumab,Entinostat,Myeloid-derived suppressor cells
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要